ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2020. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,265,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |